Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Janelle Robinson"'
Autor:
Susan Conroy, Trish Evans, Dana Butler-Moburg, Richard Beuttler, Janelle Robinson, Matt Huebert, Erin O Mahony, Marybeth Grant-Beuttler
Publikováno v:
Physiotherapy theory and practice.
Hippotherapy (HPOT) is a physical therapy (PT) treatment tool using equine movement to improve mobility for children with movement impairments. Although research suggests HPOT improves body structure and function, there is limited evidence regarding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471f2bc2cacc9240a269a9cd4a2aed2f
https://pubmed.ncbi.nlm.nih.gov/35594061
https://pubmed.ncbi.nlm.nih.gov/35594061
Autor:
Emily Camilleri, Janelle Robinson, Melissa J. Caimano, George Korza, Ralf Moeller, Peter Setlow, Katja Nagler, Joshua Green
Publikováno v:
Journal of bacteriology. 201(9)
Large-scale shotgun sequencing (RNA-seq) analysis of mRNAs in dormant Bacillus subtilis spores prepared on plates or in liquid generally found the same ∼46 abundant mRNA species, with >250 mRNAs detected at much lower abundances. Knowledge of the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8997bfda316bbb5414bcaa9b746fe05a
https://pubmed.ncbi.nlm.nih.gov/30782632
https://pubmed.ncbi.nlm.nih.gov/30782632
Autor:
Ainah U. Tan, William H. Matthai, Sylvia E. Rosas, Robert L. Wilensky, Janelle Robinson, Maura Munoz
Publikováno v:
American Journal of Nephrology. 27:247-252
Background/Aim: Electron-beam computerized tomography (EBCT) is able to noninvasively quantify coronary artery calcification (CAC). Chronic kidney disease (CKD) patients frequently have CAC, and clinicians are puzzled regarding the clinical significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c0330b85e436d522f4cdc462a2fe0f3
https://doi.org/10.1159/000101370
https://doi.org/10.1159/000101370
Autor:
Marshall M. Joffe, Janelle Robinson, Carmen Guerra, K. Schankel, Sylvia E. Rosas, Daniel J. Rader, Roy D. Bloom
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 7(9)
Coronary artery calcification (CAC) is associated with increased atherosclerotic burden and cardiovascular events. The objective of this study was to determine the natural history and risk factors associated with CAC progression in a cohort of incide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466acff83a5df44fd8d5547d4d6dbec5
https://pubmed.ncbi.nlm.nih.gov/17640315
https://pubmed.ncbi.nlm.nih.gov/17640315
Autor:
David J. Vaughn, Jean H. Hoffman-Censits, Scott Eliasof, Edward Graeme Garmey, Naomi B. Haas, Mary Walicki, Janelle Robinson, Ronac Mamtani, Orvar Gunnarsson, Andrew B. Nixon, Meliessa Hennessey, Abigail L Smith, Roger B. Cohen, Anthony Piscitelli, Stephen M. Keefe, Lata Jayaraman
Publikováno v:
Journal of Clinical Oncology. 33:4543-4543
4543 Background: VHL inactivation occurs in most clear cell RCCs and results in expression of the HIF hypoxia response program and tumor angiogenesis. Antiangiogenic therapies are central to therap...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31a14e51c2db173a7e5231d6538a2600
https://doi.org/10.1200/jco.2015.33.15_suppl.4543
https://doi.org/10.1200/jco.2015.33.15_suppl.4543
Autor:
Janelle Robinson, Terry Hyslop, William Kevin Kelly, Naomi B. Haas, Brooke Kennedy, Swati Nanda, Monica McGuire, Andrea B. Apolo, Stephen M. Keefe, David J. Vaughn, Jianqing Lin, Kattie Khadar, Jean H. Hoffman-Censits
Publikováno v:
Journal of Clinical Oncology. 32:e15519-e15519
e15519 Background: There is no standard second line therapy for metastatic urothelial cancer (mUC) following platinum chemotherapy (CT). Taxanes have shown clinical activity in this setting. Cabazi...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::941f02a2526f09730cc9866db56ae234
https://doi.org/10.1200/jco.2014.32.15_suppl.e15519
https://doi.org/10.1200/jco.2014.32.15_suppl.e15519
Autor:
Naomi B. Haas, Stephen M. Keefe, David J. Vaughn, Roger B. Cohen, Janelle Robinson, Jean H. Hoffman-Censits, Edward Graeme Garmey, Meliessa Hennessey, Scott Eliasof, Katherine L. Nathanson, Daniel A. Pryma, Orvar Gunnarsson, Kristine Mykulowicz, Ronac Mamtani
Publikováno v:
Journal of Clinical Oncology. 32:e15611-e15611
e15611 Background: VHL is inactivated in most clear cell RCC (ccRCC) giving rise to the HIF hypoxia response program and tumor angiogenesis. Antiangiogenic therapies are active in ccRCC, but resist...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcd8edf51e8d2bcc128e42f93da9eb8e
https://doi.org/10.1200/jco.2014.32.15_suppl.e15611
https://doi.org/10.1200/jco.2014.32.15_suppl.e15611
Autor:
Kristine Mykulowicz, Amy Marshall, Naomi B. Haas, Roger B. Cohen, Ronac Mamtani, Jean H. Hoffman-Censits, Priti Lal, Scott Eliasof, Daniel A. Pryma, Edward Graeme Garmey, Meliessa Hennessey, Stephen M. Keefe, Orvar Gunnarsson, Janelle Robinson, Katherine L. Nathanson, David J. Vaughn, Daniel F. Heitjan
Publikováno v:
Journal of Clinical Oncology. 32:412-412
412 Background: VHL is inactivated in most clear cell RCC (ccRCC) tumors giving rise to the HIF hypoxia response program and tumor angiogenesis. Antiangiogenic therapies are active in ccRCC, but resistance develops in all pts. Dual inhibition strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a9dff1cd558abb63cd39764d2c38018
https://doi.org/10.1200/jco.2014.32.4_suppl.412
https://doi.org/10.1200/jco.2014.32.4_suppl.412
Autor:
Naomi B. Haas, David J. Vaughn, Amy Marshall, Janelle Robinson, Mark A. Rosen, Ronac Mamtani, Daniel A. Pryma, Stephen M. Keefe, Peter J. O'Dwyer, Karen McGibney
Publikováno v:
Journal of Clinical Oncology. 32:406-406
406 Background: Carbonic anhydrase IX (CAIX), a transmembrane glycoprotein with an intracellular enzymatic domain, is overexpressed in ccRCC as a result of VHL loss. Chimeric antibody girentuximab is a monoclonal antibody that binds an extracellular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a38d0944f5eef069a1ad00911b779a60
https://doi.org/10.1200/jco.2014.32.4_suppl.406
https://doi.org/10.1200/jco.2014.32.4_suppl.406